JPRN-UMIN000047544已完成未知
Efficacy trial of single intake of plant derived ingredient on glucose metabolism. [n2017006] - Efficacy of plant derived ingredient [n2017006]
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 18
研究概览
简要总结
A significant difference was observed in the orimary outcome.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 60years-old(—)
- 性别
- Male
入选标准
- 未提供
排除标准
- •(1) Diabetes mellitus (2) Having history or presence of cardiovascular disease or cerebrovascular disease (3) Presence of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (4) Having history of resection of gastrointestinal tract (5) Thyroid deficiency (6) Smoker (7) Heavy alcohol drinker (over 30g per day) (8) Donated over 200 mL of blood within the last one month prior to the study or over 400 mL of blood within the last three months prior to the study (9) Severe anemia (Hb <=7g/dL) (10) Feeling sick due to blood collection (11) Food allergies for test meals (12) Food allergies for test foods (13) Cannot take all of the test food (14) Planned to participate in other clinical study during current study (15) Determined to be unqualified by the physician in charge or the responsible person of the study
研究者
相似试验
已完成
不适用
Efficacy trial of single intake of plant derived ingredient. [g2018003]Adults with diabetic range of fasting glucose (fasting plasma glucose, 126-160 mg/dl)JPRN-UMIN000032374Kao Corporation9
已完成
不适用
Efficacy trial of single intake of plant derived ingredient. [g2019004]Healthy adultsJPRN-UMIN000037738Kao Corporation18
已完成
不适用
Efficacy trial of single intake of plant derived ingredient. [g2018002]Adults with high normal and impaired fasting glucose (fasting plasma glucose, 100-125 mg/dl)JPRN-UMIN000032373Kao Corporation18
已完成
不适用
Efficacy trial of single intake of plant derived ingredient. [n2019005]Healthy adultsJPRN-UMIN000037243Kao Corporation12
已完成
不适用
Efficacy trial of ingestion of plant derived ingredient. [g2020004(KO22)]Healthy adultsJPRN-UMIN000041485Kao Corporation16
